Episodes

  • CAR T-cell Therapy in Australia: Paradigm Changing Technology

    CAR T-cell Therapy in Australia: Paradigm Changing Technology
    May 28 2024
    In this PCPA Podcast Dr Ian Irving, PCPA Board Member, Haematologist and Chief Medical Officer at ICON Group, discusses CAR T-cell therapy, a transformative approach reshaping the landscape of haematologic malignancies. CAR T-cell therapy leverages a patient's own immune system to target and eradicate cancer cells with remarkable precision. Throughout this episode, we delve into the mechanisms of action, clinical trial data, and practical considerations for integrating CAR T-cell therapy into your practice. Ian is joined by Associate Professor Mary Ann Anderson, Haematologist from the Peter MacCallum Cancer Centre in Melbourne and Dr Allison Barraclough, Haematologist from the Fiona Stanley Hospital in Perth.
    Show more Show less
    33 mins
  • Leadership Stories: Women in Oncology Research

    Leadership Stories: Women in Oncology Research
    Mar 7 2024
    In this PCPA Podcast we focus on Leadership Stories: Women in Oncology Research, launched on International Women’s Day 2024. Professor Fran Boyle, Medical Oncologists and Supportive care Physician from the Mater Hospital in Sydney discusses the unique challenges and opportunities with Professor Victoria Atkinson from Greenslopes Private Hospital and the Princess Alexandra Hospital in Brisbane and also Dr Amy Davies, Medical Oncologist and Research Scientist from Victoria. We tackle: Is it necessary to go overseas to progress your career? Can you do great research in the private sector? What are the special qualities and strengths women bring to cancer care? This episode is a powerful tribute to the remarkable women who are shaping the future of cancer research and making a significant impact on the lives of thousands of cancer patients. It's a reminder of the importance of diversity and inclusion in scientific research and the crucial role women play in driving innovation and progress.
    Show more Show less
    33 mins
  • The What, When, Why and How of IDH Mutations in Cancer

    The What, When, Why and How of IDH Mutations in Cancer
    Jan 29 2024
    In this PCPA podcast we discuss The What, When, Why and How of IDH Mutations in Cancer? The discussion covers the understanding of IDH mutations in cancer, a completely new enzyme driving cancer in both solid tumours and in haematology. Experts are on hand to cover the nuances in molecular testing and review current and future therapies and trends in these patient populations. Dr Shehara Mendis, Medical Oncologist from Cabrini Hospital in Melbourne chairs this discussion with Dr Michael Rodriguez, Consultant Neuropathologist, St Vincent's Hospital and POW Hospital Sydney; Douglass Hanly Moir Pathology and Associate Professor Daniel Thomas, a Clinical Haematologist and Cancer Scientist from the University of Adelaide.
    Show more Show less
    29 mins
  • Most Patients With Cancer are Older - How Does this Impact their Care?

    Most Patients With Cancer are Older - How Does this Impact their Care?
    Dec 17 2023
    In this PCPA podcast we discuss “Most Patients With Cancer are Older - How Does this Impact their Care?” The conversation explores this specialised field which focuses on the care of older adults with cancer. Since more than 50% of patients will be over 65 years of age in the next few years and as an oncologist treating older patients with cancer, it's crucial to understand the unique challenges and considerations involved in their care . A/Professor Christopher Steer , medical oncologist from Albury/Wodonga and President of the Private Cancer Physicians of Australia is joined by Dr Etienne Brain, MD, PhD, senior medical oncologist at Institut Curie, in Saint-Cloud, France, who was honoured with the 2022 B.J. Kennedy Geriatric Oncology Award for his career-long contributions to advancing clinical research in breast cancer in older populations.
    Show more Show less
    24 mins
  • Voluntary Assisted Dying: What you need to know

    Voluntary Assisted Dying: What you need to know
    Sep 18 2023
    Dr Cameron McLaren, Medical Oncologists and PCPA Board Member from Victoria is joined by Laurie Draper, a voluntary assisted dying care navigator from the State-wide Care Service in Melbourne and Dr Hilda High Medical Oncologist specialising in Cancer Genetics from Sydney. In this Private Cancer Physician of Australia podcast they discuss voluntary assisted dying and what you need to know as a health care professional to manage the change in care. With the impending changes around the country regarding voluntary assisted dying Dr Hilda High asks pertinent questions for health professionals to Cam and Laurie to draw on their experience with their program in Victoria. https://www.gogentleaustralia.org.au/conference_2023 - VAD National Conference 2023 https://cesphn.org.au/news/voluntary-dying-conference - NSW VAD Implementation Conference 2023
    Show more Show less
    37 mins
  • Precision Medicine for Australian Patients with Cancer

    Precision Medicine for Australian Patients with Cancer
    Jun 28 2023
    Molecular profiling plays a crucial role in optimizing cancer care by enabling personalized treatment decisions, improving treatment outcomes, and offering potential avenues for targeted therapies and clinical trial participation. In this PCPA Podcast, Professor Desmond Yip, PCPA Secretary and Treasurer and Senior Staff Specialist in Medical Oncology at the Canberra Hospital is joined by Professor Lorraine Chantrill, Senior Staff Specialist Medical Oncologist and Head of Service for Medical Oncology across the Illawarra Shoalhaven Local Health District (ISLHD), and Area Clinical Director of Clinical Trials and also Dr Vivek Rathi, Director of Operations, Group Medical Director, Group Molecular Pathologist at LifeStrands Genomics. In this podcast, they discuss precision medicine for Australian patients with cancer, current genetic pathology and actionable targets. We look to the future of comprehensive genomic profiling (CGP) and how to make this a clinical solution for all. The PCPA is a dynamic, not-for-profit Oncology specialist organisation that aims to improve the care of cancer patients in the private health system, believing that cancer care should be the best it can be for our patients, their families and our members who are entrusted to care for them.
    Show more Show less
    28 mins
  • Antibody-Drug Conjugates: Transforming Breast Cancer Treatment

    Antibody-Drug Conjugates: Transforming Breast Cancer Treatment
    May 24 2023
    The Private Cancer Physician’s Podcast series on Managing Patients with Cancer is pleased to release its new podcast: Antibody-Drug Conjugates: Transforming Breast Cancer Treatment In this podcast, we discuss antibody-drug conjugates (ADCs) and the transformative role they are playing in the fight against metastatic breast cancer. ADCs are “smart bombs” that provide a new construct to treat metastatic breast cancer, with higher efficacy and less off target toxicities. Dr Richard de Boer, Medical Oncologist from the Peter MacCallum Cancer Centre is joined by Professor Hope Rugo, Director, Breast Oncology and Clinical Trials Education and Medical Director of Cancer Infusion Services, UCSF as well as Dr Belinda Yeo, Medical Oncologist from the Austin Hospital in Melbourne, Australia, and Clinician Scientist from the Olivia Newton-John Cancer Research Institute. Produced by ScienceToLife
    Show more Show less
    23 mins
  • The Patient Doctor

    The Patient Doctor
    Feb 24 2023

    Music:  Take My Time by The Sun Tones

    Produced by SciencetoLife
    Show more Show less
    30 mins